valor de las acciones
Competidores
| Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
161.28 | -20.61% | -10.12% | 284,799.16 | 3.86% | 7.03% |
|
NasdaqGS:AMGN
Amgen
|
308.45 | -11.11% | -2.21% | 165,463.28 | 2.9% | 5.31% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.54 | 21.22% | 30.5% | 84,144.93 | 4.67% | 0.15% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40,336.01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
225.34 | -13.26% | 2.13% | 32,808.8 | 0% | -10.89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
80.50 | 142.2% | 221.62% | 15,385.96 | 0% | 32.46% |
|
NasdaqGS:INCY
Incyte
|
57.60 | 104.81% | 153.29% | 12,012.93 | 0% | 27.62% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
108.05 | 0% | 0% | 6,783.92 | 0% | 0% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6,165.32 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
10.88 | 0% | 0% | 3,763.74 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3,739.11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3,724.47 | 0% | 0% |
|
NasdaqGS:ARWR
Arrowhead Pharmaceuticals
|
22.06 | 0% | 0% | 3,062.73 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2,986.1 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
9.04 | 0% | 0% | 2,807.75 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
40.11 | 0% | 0% | 2,631.15 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
15.18 | 0% | 0% | 2,512.75 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
48.52 | -94.78% | -76.15% | 2,364.47 | 0% | 0% |
|
NasdaqGM:ADMA
ADMA Biologics
|
8.79 | 0% | 0% | 2,042.24 | 0% | 0% |
|
NasdaqGM:ARDX
Ardelyx
|
8.02 | 0% | 0% | 2,040.28 | 0% | 0% |
